$PMCB has received the "orphan drug" designation from the FDA for their pancreatic cancer treatment. They're seeking the same type of approval in Europe and Australia.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.